SRTA Earnings & Financial Statements
Strata Critical Medical, Inc.
$4.35
+$0.07(+1.66%)
45
Overall
80
Value
9
Tech
47
Quality
Market Cap
$378.64M
Volume
629.30K
52W Range
$3.95 - $6.50
Target Price
$9.19
SRTA earnings and financial statements: Strata Critical Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
SRTA Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $197.14M | $146.82M | $225.18M | $146.12M | $50.53M |
| Cost of revenue | $156.01M | $117.23M | $183.06M | $123.84M | $40.01M |
| Operating income | -$22.35M | -$22.52M | -$68.12M | -$53.53M | -$24.09M |
| EBITDA | $45.29M | -$28.56M | -$58.87M | -$47.80M | -$23.50M |
| Net income | $41.35M | -$27.31M | -$56.08M | -$27.26M | -$40.05M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $325.47M | $256.68M | $294.94M | $325.02M | $6.95M |
| Total liabilities | $46.40M | $34.74M | $60.64M | $50.54M | $52.16M |
| Shareholders’ equity | $279.07M | $221.94M | $234.30M | $274.49M | $291.23M |
| Cash and equivalents | $30.97M | $18.38M | $27.87M | $41.34M | $6.95M |
| Long-term debt | $2.65M | $2.34M | $19.74M | $14.97M | $222.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$48.91M | -$2.52M | -$32.35M | -$37.13M | -$15.62M |
| Capital expenditure | -$11.01M | -$32.98M | -$2.11M | -$730.0K | -$801.0K |
| Free cash flow | -$59.92M | -$35.50M | -$34.46M | -$37.86M | -$16.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRTA | $4.35 | +1.7% | 629.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Strata Critical Medical, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW